Page 1 | Search Results | Blood Advances | American Society of Hematology

1-20 of 4813

Sort by

Sort Order Select

Journal Articles

HIV infection is associated with compromised tumor microenvironment adaptive immune reactivity in Hodgkin lymphoma

Amanda Chantziou, Cloe Brenna, Kalliopi Ioannidou, Oliver Y. Chen, Penelope Korkolopoulou, Anastasia Antoniadou, Mina Psichogiou, Maria Papaioannou, Panagiotis Tsirigotis, Periklis G. Foukas, Laurence de Leval, Constantinos Petrovas

Blood Adv (2024) 8 (24): 6215–6231.

https://doi.org/10.1182/bloodadvances.2023012116

Published: 2024

Includes: Supplemental data

Journal Articles

Evolving consolidation patterns and outcomes for a large cohort of patients with primary CNS lymphoma

Kathryn R. Tringale, Michael Scordo, Joachim Yahalom, Charlie White, Zhigang Zhang, Javin Schefflein, Gustav Cederquist, Lauren R. Schaff, Lisa DeAngelis, Brandon S. Imber, Christian Grommes

Blood Adv (2024) 8 (24): 6195–6206.

https://doi.org/10.1182/bloodadvances.2024013780

Published: 2024

Includes: Supplemental data

Journal Articles

Efficacy and safety of TPO receptor agonists in treatment of ITP associated with predominantly antibody deficiencies

Margaux Soulard, Lionel Galicier, Nizar Mahlaoui, Claire Fieschi, Samuel Deshayes, Delphine Gobert, Clément Gourguechon, Hélène Henique, Sebastien Humbert, Carole Lacout, Ronan Le Calloch, Marc Michel, Marie-lea Piel-julian, Jean François Viallard, Alain Lescoat, Bertrand Godeau, Antoinette Perlat

Blood Adv (2024) 8 (24): 6171–6182.

https://doi.org/10.1182/bloodadvances.2024014370

Published: 2024

Journal Articles

Identification of factors predicting low-risk febrile neutropenia admissions in adults with acute myeloid leukemia

Khushboo V. Pal, Megan Othus, Zahra Ali, Katherine Russell, Carole Shaw, Mary-Elizabeth M. Percival, Paul C. Hendrie, Jacob S. Appelbaum, Roland B. Walter, Anna B. Halpern

Blood Adv (2024) 8 (24): 6161–6170.

https://doi.org/10.1182/bloodadvances.2024014291

Published: 2024

Includes: Supplemental data

Journal Articles

Guideline concordance of aspirin use for primary prevention in adult outpatients

Naina Chipalkatti, Geoffrey D. Barnes, Linda Bashaw, Adam Davie, Jennifer J. Griggs, Molly Harrod, Jacob E. Kurlander, Christine Medaugh, Rebeca Packard, Corey Powell, Suman Sood, Elizabeth Spranger, Sarah E. Vordenberg, Jordan K. Schaefer

Blood Adv (2024) 8 (24): 6207–6214.

https://doi.org/10.1182/bloodadvances.2024014220

Published: 2024

Includes: Supplemental data

Journal Articles

Sustained remission at long term follow-up in adolescents and young adults with chronic primary immune thrombocytopenia

Alexandra Schifferli, Gautier Le Gavrian, Nathalie Aladjidi, Guillaume Moulis, Bertrand Godeau, Thierry Leblanc, Sébastien Héritier, Helder Fernandes, Thomas Kühne

Blood Adv (2024) 8 (24): 6183–6194.

https://doi.org/10.1182/bloodadvances.2024014381

Published: 2024

Includes: Supplemental data

Journal Articles

American Society of Hematology: building a comprehensive minority recruitment and retention professional program

Margo R. Rollins, Rahma M. Warsame, Melody Smith, Arturo Molina, Rayne H. Rouce, Belinda R. Avalos, Cage S. Johnson, Jose A. Lopez, Alexis A. Thompson, Lisa Fanning, Patricia Frustace, Keelin Roche, Nathalie van Havre, Devon Mack, Christopher R. Flowers, Deirdra R. Terrell

Blood Adv (2024) 8 (24): 6237–6247.

https://doi.org/10.1182/bloodadvances.2024013519

Published: 2024

Journal Articles

Impact of thrombocytopenia on bleeding and thrombotic outcomes in adults with cancer-associated splanchnic vein thrombosis

Michael Andersen, Jr., Maria J. Fernandez Turizo, Laura E. Dodge, Charles Hsu, Kevin Barnum, Jonathan Berry, Jeffrey I. Zwicker, Rushad Patell

Blood Adv (2024) 8 (24): 6151–6160.

https://doi.org/10.1182/bloodadvances.2024014249

Published: 2024

Includes: Supplemental data

Journal Articles

Time to revisit reduced-dose radiotherapy for PCNSL?

Maciej Tatarczuch

Blood Adv (2024) 8 (24): 6234–6236.

https://doi.org/10.1182/bloodadvances.2024014588

Published: 2024

Journal Articles

Lin A, Brown S, Chinapen S, et al. Patterns of CMV infection after letermovir withdrawal in recipients of posttransplant cyclophosphamide–based transplant. Blood Adv. 2023;7(23):7153-7160.

Blood Adv (2024) 8 (24): 6232–6233.

https://doi.org/10.1182/bloodadvances.2024014741

Published: 2024

Journal Articles

Loss of protein C vs protein S results in discrepant thrombotic phenotypes

Chia-Jui Ku, Xinge Yu, Queena Yakun Zhao, Steven J Grzegorski, Jeffrey G Daniel, Allison C Ferguson, Jordan A Shavit

Blood Adv bloodadvances.2024013237.

https://doi.org/10.1182/bloodadvances.2024013237

Published: 2024

Includes: Multimedia, Supplemental data

Journal Articles

NAD+ METABOLISM RESTRICTION BOOSTS HIGH-DOSE MELPHALAN EFFICACY IN PATIENTS WITH MULTIPLE MYELOMA

Blood Adv bloodadvances.2024013425.

https://doi.org/10.1182/bloodadvances.2024013425

Published: 2024

Includes: Supplemental data

Journal Articles

Safety and Efficacy of Glofitamab for Relapsed/Refractory Large B-Cell Lymphoma in a Multinational Real-World Study

Blood Adv bloodadvances.2024014903.

https://doi.org/10.1182/bloodadvances.2024014903

Published: 2024

Includes: Supplemental data

Journal Articles

Risk of bleeding in patients with essential thrombocythemia and extreme thrombocytosis

Rathnam K. Venkat, Robert A. Redd, Amyah C. Harris, Martin J. Aryee, Anna E. Marneth, Baransel Kamaz, Chulwoo J. Kim, Mohammed Wazir, Lachelle D. Weeks, Maximilian Stahl, Daniel J. DeAngelo, R. Coleman Lindsley, Marlise R. Luskin, Gabriela S. Hobbs, Joan How

Blood Adv (2024) 8 (23): 6043–6054.

https://doi.org/10.1182/bloodadvances.2024013777

Published: 2024

Includes: Supplemental data

Journal Articles

JAK2 p.R564 germ line variants associated with hereditary thrombocythemia and hematologic neoplasms

Brittany L Stewart, Hetty E Carraway, Adriana L Alvarez, Harry Lesmana, John C Molina, Zheng Jin Tu, David S Bosler, Aaron T. Gerds, Babal K Jha, Emilia Calvaresi, Joy Nakitandwe, Abhay Singh

Blood Adv bloodadvances.2024013661.

https://doi.org/10.1182/bloodadvances.2024013661

Published: 2024

Journal Articles

Health care Systems as Determinants of Outcomes in Multiple Myeloma: Final Results from the Latin American MYLACRE Study

Blood Adv bloodadvances.2024013838.

https://doi.org/10.1182/bloodadvances.2024013838

Published: 2024

Journal Articles

Lisocabtagene Maraleucel for Relapsed/Refractory Large B-Cell Lymphoma: A Cell Therapy Consortium Real-World Analysis

Peter A. Riedell, Connor B. Grady, Loretta J. Nastoupil, Alejandro Luna De Abia, Nausheen Ahmed, Richard T. Maziarz, Marie Hu, Jamie Brower, Wei-Ting Hwang, Stephen J. Schuster, Andy I. Chen, Olalekan O. Oluwole, Veronika Bachanova, Joseph P. McGuirk, Miguel-Angel Perales, Michael R. Bishop, David L. Porter

Blood Adv bloodadvances.2024014164.

https://doi.org/10.1182/bloodadvances.2024014164

Published: 2024

Includes: Supplemental data

Journal Articles

Lezina L, Spriggs RV, Beck D, et al. CD40L/IL-4–stimulated CLL demonstrates variation in translational regulation of DNA damage response genes including ATM. Blood Adv. 2018;2(15):1869-1881.

Blood Adv (2024) 8 (23): 6028.

https://doi.org/10.1182/bloodadvances.2024014025

Published: 2024

Journal Articles

Gene therapy for hemophilia

Peter J. Lenting, Sylvia Fong

Blood Adv (2024) 8 (23): 6081.

https://doi.org/10.1182/bloodadvances.2024013864

Published: 2024

Journal Articles

Model-based dosing for better survival after transplantation

Jaap Jan Boelens, Michael Scordo

Blood Adv (2024) 8 (23): 6064–6066.

https://doi.org/10.1182/bloodadvances.2024014236

Published: 2024

NARROW

HIV infection is associated with compromised tumor microenvironment adaptive immune reactivity in Hodgkin lymphoma

Evolving consolidation patterns and outcomes for a large cohort of patients with primary CNS lymphoma

Efficacy and safety of TPO receptor agonists in treatment of ITP associated with predominantly antibody deficiencies

Identification of factors predicting low-risk febrile neutropenia admissions in adults with acute myeloid leukemia

Guideline concordance of aspirin use for primary prevention in adult outpatients

Sustained remission at long term follow-up in adolescents and young adults with chronic primary immune thrombocytopenia

American Society of Hematology: building a comprehensive minority recruitment and retention professional program

Impact of thrombocytopenia on bleeding and thrombotic outcomes in adults with cancer-associated splanchnic vein thrombosis

Time to revisit reduced-dose radiotherapy for PCNSL?

Lin A, Brown S, Chinapen S, et al. Patterns of CMV infection after letermovir withdrawal in recipients of posttransplant cyclophosphamide–based transplant. Blood Adv. 2023;7(23):7153-7160.

Loss of protein C vs protein S results in discrepant thrombotic phenotypes

NAD+ METABOLISM RESTRICTION BOOSTS HIGH-DOSE MELPHALAN EFFICACY IN PATIENTS WITH MULTIPLE MYELOMA

Safety and Efficacy of Glofitamab for Relapsed/Refractory Large B-Cell Lymphoma in a Multinational Real-World Study

Risk of bleeding in patients with essential thrombocythemia and extreme thrombocytosis

JAK2 p.R564 germ line variants associated with hereditary thrombocythemia and hematologic neoplasms

Health care Systems as Determinants of Outcomes in Multiple Myeloma: Final Results from the Latin American MYLACRE Study

Lisocabtagene Maraleucel for Relapsed/Refractory Large B-Cell Lymphoma: A Cell Therapy Consortium Real-World Analysis

Lezina L, Spriggs RV, Beck D, et al. CD40L/IL-4–stimulated CLL demonstrates variation in translational regulation of DNA damage response genes including ATM. Blood Adv. 2018;2(15):1869-1881.

Gene therapy for hemophilia

Model-based dosing for better survival after transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only